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Abstract  
Objectives 
To conduct a geographically defined, UK-based case-control study, to examine any 
association between physical activity (PA) and amyotrophic lateral sclerosis (ALS).   
Methods 
A novel historical PA questionnaire was designed, validated, and subsequently 
administered in individual face-to-face interviews of 175 newly diagnosed sporadic 
ALS cases and 317 age- and sex-matched community controls.  Historical PA energy 
expenditure and time spent in vigorous-intensity PA were derived from questionnaire 
data and compared between cases and controls.  
Results 
Participation in an extra 10kJ/kg/day of PA (equivalent to approximately 45minutes 
brisk walking) was consistently associated with an increased risk of ALS, with the 
strongest association observed for adulthood exercise-related PA (OR 1.47, 95% CI 
1.10-1.97).  An extra 10mins/day of vigorous PA was also associated with the odds 
of ALS (OR 1.03, 95% CI 1∙01-1∙05). Results were slightly attenuated following 
adjustment for smoking and educational attainment.  
Conclusions 
To our knowledge this is the first study to demonstrate a positive association 
between ALS and PA participation using a specifically designed and validated 
historical PA questionnaire.  Despite the well-established health benefits of PA, a 
high activity lifestyle may also be associated with elevated risk of ALS.   Large-scale 
prospective studies in the future may help to confirm this association. 
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Introduction 
Amyotrophic lateral sclerosis (ALS) is a disabling, terminal neurodegenerative 
condition characterised by progressive paralysis and atrophy of limb, bulbar and 
ultimately respiratory muscles.  Population-based research demonstrates 
geographical variation in incidence, with an annual incidence in Europe and North 
America of  approximately 2 per 100,000 (1, 2) and lower incidence suggested in 
African, Asian and Hispanic populations (3).     
Epidemiological, biological and genetic research suggests a complex pathogenic 
interaction between genetic and environmental exposures (4).  However, aside from 
inherent risk associated with genotype, age and gender, very few exogenous 
causative factors have been confirmed.  The strongest evidence relates to smoking, 
which was associated with incident ALS in a recent meta-analysis of prospective 
studies including over 1 million participants (5).  Following proposals of an 
association between physical activity (PA) and the development of ALS (6), several 
observational studies have examined this hypothesis, with inconsistent results (7-11).  
Reports of elevated ALS incidence in Italian professional footballers stimulated 
further epidemiological research (12-14).  However, methodological challenges 
when examining exogenous associations with relatively rare diseases, particularly 
regarding sample size, bias minimisation, and valid exposure quantification, have 
limited the conclusions drawn, though recent studies have improved on some of 
these concerns (15, 16).   
Beyond epidemiology, it has been proposed that elevated tissue metabolism and 
motor neuron firing during exercise augment oxidative stress and glutamate 
excitotoxicity-related motor neuron degeneration (17, 18).  Several genes associated 
   5 Harwood
  
 5 
with ALS are also known to be up-regulated by PA (19, 20).  Homeostatic 
abnormalities in ALS which may respond to PA participation provide an alternative 
mechanism for a disease association (21).  
We hypothesised that participation in a high level of PA is associated with an 
increased risk of sporadic ALS.  Our objectives were to conduct a case-control study, 
recruiting a UK-based study population, to determine any association between PA 
and ALS.   
Materials and Methods 
ALS patients and community controls were recruited between July 2009 and July 
2013 from a geographically defined population within Northern England comprising 
approximately 7∙6 million individuals.  Relevant NHS and university research ethical 
approvals were obtained and procedures followed were in accordance with these 
standards.  All study participants provided informed consent. 
Study population 
Individuals with clinically definite, probable or possible sporadic ALS (22), were 
identified from hospital and community ALS services.  Patients were eligible if 
recruited within 6 months of diagnosis to ensure near-incident rather than long-
prevalent cases.  Those with any family history of ALS or concurrent 
neurodegenerative disease were excluded.  Potential controls were identified from a 
selection of general medical practices within the same regions, covering a broad 
spectrum of patient demographics.  To recruit two controls per case, 10 individuals 
without an active neurological diagnosis, and matched to each case by date of birth 
(+/- 5 years) and gender, were randomly selected for invitation by their general 
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practitioners. All eligible participants were sent written information about the study, 
and individual appointments arranged with those who decided to participate.  
Data collection 
Face-to-face interviews, lasting approximately 90 minutes, were conducted with 
each participant by one of two interviewers, using a standardised approach.  PA data 
were collected using a novel, valid electronic questionnaire, the Historical Adulthood 
Physical Activity Questionnaire (HAPAQ)(23).  In brief, HAPAQ collects data 
regarding total adulthood PA at home, work and in leisure (exertional sport and 
casual exercise). Closed questions regarding the nature, frequency and duration of 
activities are asked in periods of 5 or 10 years, using a life calendar of significant 
events to aid recall.  Participants were blinded to the research hypothesis.    
Data reduction from the questionnaire 
To quantify PA volume, PA energy expenditure (PAEE) scores for each activity 
were derived from questionnaire data using the Compendium of Physical Activities 
(24).  This resource quantifies the energy expenditure of activities as a ratio with 
standard resting metabolic rate, expressed as metabolic equivalents (METs), with 
one MET equivalent to an approximate oxygen consumption of 3∙5ml O2/kg/min.  
MET intensity values for each reported activity were identified from the 
Compendium, subtracted by 1 MET for resting metabolic rate, and then multiplied 
by the reported activity durations.  The average daily PAEE (kJ/kg/day) was 
calculated using the following equation, assuming the energy equivalent of one 
litre of oxygen to be 20∙3kJ (25): 
Self-report PAEE = ∑ Duration Activityi x (MET scorei -1) x 3∙5 x 20∙3  
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Individual average daily PAEEs from occupational, leisure and total PA were 
summarised for the most recent 15 years, reflecting the period HAPAQ was 
validated, and for the whole of adulthood.  The time spent in vigorous PA, defined 
as intensity ≥6.0 METs, was also determined (26).  Data for the most recent five 
years were excluded to limit PA suppression which might result from subclinical 
disease.  When calculating total volume of PA, housework-related activity was 
excluded, following observations of an inverse association of self-reported 
housework with objectively assessed PAEE (27). 
Statistical analysis  
To detect an odds ratio (OR) of 1.8, at 80% power and an alpha value of 0.05, 175 
cases and 350 controls were required to compare participants in the highest quartile 
of total PAEE with those below the 75th centile.  
STATA/IC version 13∙0 statistical package was used for the analyses.  Baseline 
participant characteristics were tabulated by case status.  Separate conditional 
logistic regression models determined the independent ORs for the association 
between ALS and several PA exposure variables: average daily total PA, time spent 
in vigorous PA, and activity during leisure and work.  Adjustment was made for age 
as a continuous variable based on knowledge of greater ALS risk with increasing 
age, evidence of a negative correlation between age and PA in the study population, 
and plausibility of a confounding role.  As evidence regarding the association of 
smoking with ALS remains inconclusive, we present both adjusted and unadjusted 
models with regards to smoking (5, 28).  Further adjustment was made for 
educational attainment (school only or professional/vocational qualification or 
university qualification). We also examined the association between age of onset of 
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ALS (cases) or recruitment (controls) and PA participation using a linear regression 
model, formally tested using an interaction term between PA and case status.   
Results 
424 MND patients were screened for the study.  Figure 1 describes the case selection 
process.  Of those screened, 146 patients did not meet the eligibility criteria or lived 
outside the recruitment area.  34 eligible patients were too unwell or emotionally 
distressed to approach regarding research participation.  From the remaining 244 
patients, 175 were recruited.  Regarding controls, all those agreeing to participate 
and able to attend an interview within the study timeframe, were recruited.  Every 
consented participant completed the data collection process, with no missing data for 
any variables.  
Table 1 displays the baseline characteristics of the participants.  68% of cases had 
clinically definite or probable ALS.  Almost 70% of cases presented with limb-onset 
disease and 28% with bulbar-onset.  Cases and controls were similar regarding age, 
gender, smoking status and education.  Within the most recent 15 years, 28.3% of 
controls and 30.1% of ALS cases had retired from work.  
ALS cases consistently reported higher total PA, time spent in vigorous PA and PA 
in work and leisure compared to controls (Table 2 and Fig. 2).  However, the range 
of reported PA was wide and overlapping for both sets of participants.  Regarding 
domain-specific activity, 33∙4% controls and 30∙9% cases reported no adulthood 
sport participation, reflected by the lower limit of the related interquartile ranges in 
Table 2. When comparing the two time periods, 44∙8% of controls and 42∙9% of 
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cases reported no vigorous PA during the last 15 years compared to 20∙2% and 
14∙3% respectively throughout the whole of adulthood.  
Table 3 reports the ORs regarding the association between PA participation and ALS 
status.  A difference in daily PAEE of 10kJ/kg, equivalent to approximately 45 
minutes of brisk walking or 20 minutes of soccer, was consistently associated with 
an increase in the odds of having ALS.  Significantly positive associations were 
demonstrated for both time periods and across most PA domains.  The strongest 
association related to participation in higher levels of adulthood casual exercise PA 
(age adjusted OR 1∙47, 95% CI 1∙10-1∙97, p = 0.01).  Total PA throughout adulthood 
was also significantly associated with ALS (age adjusted OR 1∙09, 95% CI 1∙03-
1∙16, p = 0.002), as was undertaking an extra 10 minutes of vigorous PA per day 
(age adjusted OR 1∙03, 95% CI 1∙01-1∙05, p = 0.004).  Further adjustment for both 
smoking and educational attainment resulted in only very minor attenuation of the 
observed size of effects.  Adulthood exertional sport related activity and work related 
activity within the most recent 15 years were not significantly associated with ALS, 
possibly reflecting a reduction in power from the smaller domain-specific sample 
sizes described above.  
An earlier age of disease onset was observed with increasing adulthood PA 
participation.  Age of onset was 0∙34 years (95% CI -0∙677 to -0∙002) lower for 
every additional 10kJ/kg/day of total PAEE (p = 0∙049) and 0∙64 years (95% CI -
1∙392 to 0∙112) lower for an extra hour of vigorous PA daily (p = 0∙095).  In 
comparison, age at recruitment of the controls was 0.43 years (95% CI -0.728 to -
0.124) lower for every additional 10kJ/kg/day of total PAEE (p=0∙006) and 0.86 
years (95% CI -1.584 to -0.134) lower for an extra hour of vigorous PA daily 
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(p=0∙020).   There was no significant interaction of the effects of age on PA by case 
status (p= 0.719).     
Discussion  
To the best of our knowledge, this is the first study to use a specifically designed and 
validated PA questionnaire to demonstrate a positive association between PA and the 
development of sporadic ALS.  Positive associations were reported for all domains 
of PA and both time periods, and remained following adjustment for potential 
confounders, with the strongest associations for those reporting higher levels of 
exercise-related PA throughout adulthood.  However, our results do not support an 
earlier age of onset of ALS with greater PA participation as a similar age-related 
association was also demonstrated within the control group, reflecting a universal 
decline in PA participation with increasing age.   
Our findings are in agreement with several published studies.  ALS has been 
reported as associated with participation in various domains of PA, including soccer, 
leisure activities and varsity athletics (8, 12, 14, 29).  Conversely, some studies have 
reported no association (7, 9, 10).  Regardless of the findings, all the previous studies 
have methodological limitations, particularly relating to recruitment strategy and the 
quality of the exposure data, restricting the conclusions which can be drawn.  
Interestingly, a difference in risk between soccer (elevated) and other sports such as 
cycling and basketball (lower) has been described, resulting in proposals of soccer-
specific risk factors rather than PA participation per se, though small cohort sample 
sizes may also explain these observations (30).   
Contrasting results have been reported from two recent case-control studies: a Dutch 
study, demonstrating a positive association between ALS and leisure PA but no other 
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associations, and a European study, reporting a potential protective effect of PA 
relating to the development of ALS (15, 16).  Strengths of these studies include 
population-based recruitment and large sample sizes.  However, both studies 
reported either missing data or proxy informants for around 18% participants, 
blinding procedures were not described in the European study, and neither study 
described validity of the exposure assessment, making interpretation of their results 
more difficult.   
A recent systematic review of epidemiological studies examining the association 
between PA and ALS concluded that PA was not a risk factor, but was inconclusive 
regarding the risk associated with occupational activity and soccer (31).  Although 
useful criteria were applied to classify the reviewed evidence, these criteria do not 
consider the validity of exposure quantification, a key element in determining data 
quality (32).  The review also acknowledged significant variation in PA 
quantification methodology and resultant accuracy, suggesting this may contribute to 
inconsistent findings, such as the contrasting conclusions in the two recent studies 
(15, 16).  The use of a validated instrument in the current study goes some way 
towards addressing this limitation (23), although it should be noted that lack of 
validation of other instruments does not necessarily imply poor validity.  
Geographically-defined variations in genetic susceptibility and exposure status may 
also contribute to reported discrepancies between studies.  Differences in ALS 
susceptibility gene mutations between populations are recognised, as illustrated by 
variable prevalence of superoxide dismutase-1 (SOD1) mutations in different 
countries (33).  Work, leisure and transport-related PA patterns are also likely to 
differ between countries, raising questions regarding whether relative PA 
participation or a threshold level is aetiologically relevant.   
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The reported associations with total PAEE in the present study suggest that overall 
cumulative PA participation may be relevant in the pathogenesis of ALS.  Any 
associations between ALS and PA most likely represent interactions between 
genetically determined susceptibility and exposure to potentially modifiable lifestyle 
behaviours. Various mechanisms have been proposed to explain such a gene-
environment interaction.  As normal physiological responses to PA may interact with 
several pathogenic mechanisms relevant to ALS, exercise might act as a trigger for 
ALS, with neurodegenerative consequences in those susceptible to the effects.  
Alternatively, individuals may be unable to mount the normal physiological 
protective responses to PA, such as the compensatory rise in antioxidant capacity 
(34), due to genetic variations which simultaneously contribute to  the pathogenesis 
of ALS.  A particular genetic profile may also contribute to sporting ability and ALS 
propensity (35), simultaneously increasing ALS risk and PA participation.  This 
would be consistent with reports of lower weight and reduced cardiovascular 
morbidity in ALS patients, which may confound this ALS association (8, 36).  Also, 
hypermetabolism has been demonstrated in ALS, which could aetiologically link this 
disease and PA through exacerbation of pathogenic abnormalities in homeostasis or 
a simultaneous predisposition to ALS and PA, though conversely could just 
represent the consequences of activity participation (21, 37).  Further work is needed 
to determine the mechanisms of this potential indirect association, particularly the 
timing of homeostatic variations in relation to disease onset.   
The recent work by Huisman, Pupillo and Hamidou represent important 
contributions to understanding associations between ALS and PA, but may lead 
some to conclude that this research question has already been answered (15, 16, 31).  
However, all previous studies on this topic, including the current one, highlight the 
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challenges of a case-control study design imposed by the rarity of ALS, but we 
propose that this report represents a rational approach when examining 
environmental exposure associations with rare diseases of unknown latency period.  
We chose to focus on using a specifically designed and validated questionnaire, able 
to rank individuals according to their activity levels (23).  Although alternative PA 
questionnaires exist, few measure historical PA, with HAPAQ being the first to be 
validated against repeated historical objective activity measurements.  
Administration of HAPAQ through individual, standardised face-to-face interviews, 
using a life calendar based on key life events to aid recall, facilitated complete, 
accurate data collection.  This represents a unique approach not previously reported 
in other studies on this topic, contrasting with methodology using non-validated 
postal questionnaires, whose main advantage is the ability to achieve large 
recruitment samples.  Other strengths of the present study include clear case 
definition using established diagnostic criteria, and the recruitment of controls from a 
similar general practice patient source from which ALS cases were derived.    
Interpretation of the results should be made whilst considering potential limitations 
of this study.  As the role of C9ORF72 mutations in ALS pathogenesis had not been 
recognised at the time this study was initiated, participant genotyping was not 
routinely undertaken as the percentage of sporadic ALS cases with mutations in 
known susceptibility genes was estimated to be minimal.  However, DNA samples 
were collected and stored from the majority of study participants, thus facilitating 
future examination of potential gene-environment interactions.   
Retrospective data collection risks differential recall of exposures, with cases 
potentially overestimating activity levels, particularly if they were aware of the 
proposed association.  To minimise this, all participants were blinded to the research 
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hypothesis and uncertainty regarding any association between ALS and PA was 
made clear during each interview.  The social desirability of exercise makes PA 
overestimation a possibility, potentially biasing the result towards the null if it was 
non-differential by case status, but could bias results in either direction if it was not.  
The previously reported under- and over-reporting of PA in active and more 
sedentary individuals, respectively, by HAPAQ would have similar effects (23). 
The focus on PA and the social desirability of this behaviour may have attracted 
more active controls to participate in the study, risking selection bias.  However, this 
direction of bias would reduce the size of the disease association detected.  An 
acceptable recruitment rate was achieved (71.7%) from invited cases, though case 
ascertainment for the geographically defined recruitment population was incomplete.  
Although only partial data were available regarding eligible cases who declined 
participation, characteristics of recruited cases were comparable to the general ALS 
population, suggesting a representative case sample. Although interviewers were not 
blinded to the participants’ disease status, HAPAQ was administered in a structured 
manner dictated by time periods, ensuring standardised data collection for all 
participants and minimising interviewer bias.  
HAPAQ was validated using a mixed gender population of comparable average age 
to the participants in the present study.  However, participants in the validation 
sample were not defined by a neurological disease such as ALS and it is possible that 
ALS patients may recall PA differently.  Also, HAPAQ validity was established only 
for the most recent 15 years.  However, this does represent a historical timeframe 
and identical questions were repeated throughout each questionnaire time period.  A 
prospective cohort study design with very long follow-up time and repeated 
assessment of PA before occurrence of ALS would eliminate many of the limitations 
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already discussed.  However, given the rarity of ALS, very few existing cohort 
studies will have the potential to answer this research question.     
In summary, this study suggests a positive association between PA and the 
development of sporadic ALS using validated methodology. Although ORs 
approximate percentage risk with rare diseases, the contribution of PA to the risk of 
ALS within this study population can only be quantified by understanding the 
relevant gene-environment interaction.  With individual risk likely to be dictated by 
inherent genetic predisposition, identifying this susceptibility is imperative if advice 
regarding lifestyle modification is to be given, particularly given the established 
health benefits of PA (38, 39).  Establishing the genetic interaction would clarify 
whether PA represents a direct ALS risk factor or a proxy for one or more specific 
genotypes through which propensity to athleticism and ALS are both expressed. 
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Legends for Tables and Figures  
Table 1: Demographic and clinical characteristics of study participants.  
Quantitative values are given as medians (interquartile range).  
 
Table 2: Self-reported physical activity (PA) exposure by participants.   
 
Table 3: Odds ratios for the association of physical activity (PA) with MND per unit 
change of 10 kJ/kg/day of PA or 10 min/day of time spent in vigorous PA. 
 
Figure 1: Selection process for recruitment. 
 
Figure 2: Self-reported median daily physical activity (PA) exposure (kj/kg/day) by 
outcome.   
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Tables 
Table 1: Demographic and clinical characteristics of study participants.  
Quantitative values are given as medians (interquartile range) or n (%).  
Variable Controls (n=317) Cases (n=175) 
Basic demographics   
Number of males (%) 197 (62∙2) 109 (62∙3) 
Age (years) 65  
(full range 36-91) 
64  
(full range 26-88) 
Retired in last 15 years, n (%) 269 (28∙3) 158 (30∙1) 
El-Escorial diagnostic criteria   
Clinically definite, n (%)  45 (25∙7) 
Clinically probable, n (%)  74 (42∙3) 
Clinically probable lab-supported, n(%)  43 (24∙6) 
Clinically possible, n (%)  13 (7∙4) 
Site of onset   
Lower limb, n (%)   57 (32∙6) 
Upper limb, n (%)  65 (37∙1) 
Bulbar, n (%)  49 (28∙0) 
Respiratory, n (%)  4 (2∙3) 
Smoking status   
Non-smoker, n (%) 86 (27∙1) 50 (28∙6) 
Ex-smoker, n (%) 199 (62∙8) 108 (61∙7) 
Current smoker, n (%) 32 (10∙1) 17 (9∙7) 
Education   
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Age left fulltime education (years) 16 
 (full range 12-35) 
16  
(full range 12-25) 
School education only, n (%) 90 (28∙4) 62 (35∙4) 
Professional/vocational qualification, n 
(%) 
147 (46∙4) 84 (48∙0) 
University qualification, n (%)  80 (25.2) 29 (16.6) 
 
 
  
   23 Harwood
  
 23 
Table 2: Self-reported physical activity (PA) exposure by participants.   
Physical activity (PA) variable Controls (n=317) Cases (n=175) 
 Median IQR Median IQR 
Average daily PA during the last 5-15 
years  
    
Total PA (kJ/kg/day) 43∙1  27∙1-68∙6 48∙6  27∙7 - 76∙0 
Time spent in PA>6METs (mins/day) 2.4  0∙0-24.0 4.2  0∙0-36.0 
Work related PA (kJ/kg/day) 24∙7  11∙9-46∙7 27∙5  9∙6 - 54∙9 
Total leisure PA (kJ/kg/day) 11∙0  4∙0-21∙0 13∙2  4∙6 - 27∙5 
Exertional sport related PA
#
(kJ/kg/day) 0∙0 0∙0-7∙3 0∙0 0∙0 - 9∙8 
Casual exercise related PA
+ 
(kJ/kg/day) 5∙5 2∙2-12∙2 8∙4 3∙1 - 15∙9 
Average daily adulthood PA      
Total PA (kJ/kg/day) 48∙9 32∙6-71∙6 57∙5 35∙2 - 98∙7 
Time spent in PA>6METs (mins/day) 9.6 0∙6-30.6 13.2 1.2 - 74∙4 
Work related PA (kJ/kg/day) 33∙1 21∙5-56∙5 37∙3 22∙5 - 74∙3 
Total leisure PA (kJ/kg/day) 9∙1 4∙0-18∙2 10∙8 4∙6 - 22∙3 
Exertional sport related PA (kJ/kg/day) 2∙2 0∙0-9∙6 2∙4 0∙0 - 11∙0 
Casual exercise related PA (kJ/kg/day) 4∙3 1∙8-8∙7 5∙7 2∙5 - 10∙5 
IQR: Interquartile range 
# 
Exertional sport related PA: sporting activities causing sweating and breathlessness  
+
 Casual exercise related PA: regular gentle exercise without causing sweating and 
breathlessness
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Table 3: Odds ratios for the association of physical activity (PA) with MND per 
unit change of 10 kJ/kg/day of PA or 10 mins/day of time spent in vigorous PA. 
Physical activity (PA) variable Odds ratio
*
 
(95%CI) 
p value Odds ratio
†
 
(95%CI) 
p value 
Average daily PA in last 5-15 
years (kJ/kg/day) 
    
Total PA  1∙05 (1∙00-1∙11) 0∙038 1.04 (0.99-1.10) 0.084 
Time spent in PA >6METs 
(mins/day) 
1∙02 (1.00-1∙04) 0∙071 1.01 (0.99-1.03) 0.141 
Work related PA  1∙03 (0∙98-1∙09) 0∙259 1.02 (0.97-1.08) 0.434 
Total leisure PA  1∙19 (1∙05-1∙34) 0∙006 1.19 (1.04-1.35) 0.008 
Exertional sport related PA  1∙12 (0∙97-1∙29) 0∙132 1.12 (0.97-1.31) 0.131 
Casual exercise related PA  1∙30 (1∙08-1∙57) 0∙007 1.28 (1.06-1.55) 0.011 
Average daily adulthood PA  
(kJ/kg/day) 
    
Total PA  1∙09 (1∙03-1∙16) 0∙002 1.08 (1.02-1.15) 0.009 
Time spent in PA >6METs 
(mins/day) 
1∙03 (1∙01-1∙05) 0∙004 1.03 (1.01-1.05) 0.013 
Work related PA  1∙09 (1∙03-1∙16) 0∙006 1.08 (1.01-1.15) 0.021 
Total leisure PA  1∙17 (1∙00-1∙37) 0∙056 1.15 (0.98-1.36) 0.089 
Exertional sport related PA  1∙06 (0∙88-1∙27) 0∙539 1.04 (0.87-1.26) 0.660 
Casual exercise related PA  1∙47 (1∙10-1∙97) 0∙010 1.45 (1.08-1.96) 0.014 
*
Adjusted for age as a continuous variable 
†
 Adjusted for smoking and education as categorical variables  
